The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology GroupRyan J. Beechinor, Daniel González, Lisa Bomgaars et al.|Clinical Pharmacokinetics|2019Cited by 39
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic ModelsMichael F. Hwang, Daniel González, P. Brian Smith et al.|Antimicrobial Agents and Chemotherapy|2017Cited by 19
External Evaluation of a Gentamicin Infant Population Pharmacokinetic Model Using Data from a National Electronic Health Record DatabaseShufan Ge, Daniel González, Ryan J. Beechinor et al.|Antimicrobial Agents and Chemotherapy|2018Cited by 6
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic modelJing Zhu, Daniel J. Crona, Yi Shuan Shirley Wu et al.|Haemophilia|2021Cited by 5
Population Pharmacokinetics and Exploratory Exposure‐Response Relationships of Diazepam in Children Treated for Status EpilepticusLawrence Ku, Daniel González, Christoph P. Hornik et al.|CPT Pharmacometrics & Systems Pharmacology|2018Cited by 4